WORCESTER – When David R. Tabatadze’s small biotechnology venture ran out of money in 2013, he almost gave up on it. He went to pharmaceutical companies and “angel” investors, those individuals willing to put modest amounts of money into new businesses. None were interested in funding his research into potential genetic medicines. “That was a very rough time,” Mr. Tabatadze said. Now, however, Mr. Tabatadze is expanding ZATA Pharmaceuticals Inc. The National Institutes of Health awarded ZATA a Small Business Innovation Research grant of about $360,000 in 2014, according to federal records, which kept the company going.
Image: Boris Zavizion, David Tabatadze and Brielle Weiner in their laboratory at MBI Incubator center in Worcester, Tuesday June 14, 2016. T&G Staff/Rick Cinclair
